Biocoat
Private Company
Total funding raised: $49.5M
Overview
Biocoat is a specialized medical device services company and a recognized leader in hydrophilic coatings, operating as part of the Integer Medical Coatings platform. The company leverages its proprietary HYDAK® technology to provide custom coating solutions that improve lubricity, durability, and particulate performance for a wide array of polymer and metal substrates. With over 30 years of experience, Biocoat serves major medical device OEMs across multiple high-growth therapeutic areas, positioning itself as a critical enabler of minimally invasive medical innovation. Its business model is built on providing high-touch, full-service coating development and application services to its partners.
Technology Platform
HYDAK® proprietary hydrophilic coating technology optimized for lubricity, durability, and low particulates. Offers application via both UV and Thermal curing systems. Capabilities include coating polymers, metals, films, and in-house plasma surface treatment.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Biocoat competes with other specialized hydrophilic coating service providers (e.g., Harland Medical Systems, Surmodics, Hydromer) and the internal coating departments of large medical device manufacturers. Its key competitive advantages are its HYDAK® technology performance, dual-cure system flexibility, broad substrate expertise, and its integration into the full-service Integer platform, offering clients a single-source solution.